TNF and colitis: Thus, such experimental setup represents a clinically relevant model for studies of anti-hTNF drugs in vivo that allows dissecting the contribution of T versus non-T cell-derived TNF in fully developed “human-like” colitis and implies an important role of TNF produced by T cells in driving disease progression during colitis.